Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 23.02 | 0.15 |
| PEG Ratio (TTM) | -0.75 | 1.86 |
| P/S Ratio (TTM) | 0.67 | 1.89 |
| P/B Ratio (TTM) | 0.50 | 0.38 |
| P/FCF Ratio (TTM) | -21.20 | 19.99 |
| Price to 5YR AVG Earnings Ratio | -37.38 | -67.65 |
| Price to 5YR AVG FCF Ratio | 17.65 | 21.84 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.82% | 1.99% |
| ROE (TTM) | 2.24% | 1.64% |
| Net Profit Margin (TTM) | 2.92% | 3.61% |
| ROIC 5YR AVG | -0.20% | -0.53% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -69.56% | 143.32% | 35.53% |
| Revenue | 309.64% | 24.52% | 11.32% |
| Net Income | -72.09% | 153.22% | 35.54% |
| Cash Flow | 2,475.42% | 30.41% | 1,023.13% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.74 | 1.04 |
| Quick Ratio (TTM) | 2.96 | 0.72 |
| D/E Ratio (TTM) | 0.05 | 0.83 |
| Interest Coverage (TTM) | 6.65 | 6.38 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | 1.31 | 1.74 |
| LTL to 5YR AVG FCF | 1.48 | 4.23 |
| Shares Outstanding Growth 5YR AVG | 4.52% | 13.17% |